Smoothened Homolog (Protein Gx or SMO) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Smoothened homolog (SMO) is a G protein-coupled receptor that probably associates with the patched protein (PTCH) to transduce the hedgehog’s proteins signal. Binding of sonic hedgehog (SHH) to its receptor is thought to prevent normal inhibition by patched of smoothened (SMO). It is required for the accumulation of KIF7 and GLI3 in the cilia.
The Smoothened Homolog (Protein Gx or SMO) Drugs in Development market research report provides in-depth analysis of Smoothened Homolog (Protein Gx or SMO) targeted pipeline therapeutics. The report provides comprehensive information on the Smoothened Homolog (Protein Gx or SMO) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in Smoothened Homolog (Protein Gx or SMO) targeted therapeutics development with respective active and dormant or discontinued projects.
What is the mechanism of action in the Smoothened Homolog pipeline drugs market?
The mechanism of action in the Smoothened Homolog pipeline drugs market is Smoothened Homolog Antagonist.
What are the routes of administration in the Smoothened Homolog pipeline drugs market?
The routes of administration in the Smoothened Homolog pipeline drugs market are oral and topical.
Smoothened Homolog pipeline drugs market, by routes of administration
For more routes of administration insights, download a free report sample
What is the molecule type in the Smoothened Homolog pipeline drugs market?
The molecule type in the Smoothened Homolog pipeline drugs market is small molecule.
Which are the key companies in the Smoothened Homolog pipeline drugs market?
The key companies in the Smoothened Homolog pipeline drugs market are Pfizer Inc, Alfasigma SpA, F. Hoffmann-La Roche Ltd, Genentech USA Inc, Guangdong Zhongsheng Pharmaceutical Co Ltd, IMPACT Therapeutics Inc, Kintor Pharmaceutical Ltd, Mayne Pharma Group Ltd, Nelum Corp, Nostopharma LLC, and PellePharm Inc.
Smoothened Homolog pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report overview
Mechanism of Action | Smoothened Homolog Antagonist |
Routes of Administration | Oral and Topical |
Molecule Type | Small Molecule |
Key Companies | Alfasigma SpA, F. Hoffmann-La Roche Ltd, Genentech USA Inc, Guangdong Pfizer Inc, Alfasigma SpA, F. Hoffmann-La Roche Ltd, Genentech USA Inc, Guangdong Zhongsheng Pharmaceutical Co Ltd, IMPACT Therapeutics Inc, Kintor Pharmaceutical Ltd, Mayne Pharma Group Ltd, Nelum Corp, Nostopharma LLC, and PellePharm Inc. |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Smoothened Homolog (Protein Gx or SMO).
- Reviews of pipeline therapeutics for Smoothened Homolog (Protein Gx or SMO) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Smoothened Homolog (Protein Gx or SMO) therapeutics and enlists all their major and minor projects.
- Assessment of Smoothened Homolog (Protein Gx or SMO) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Smoothened Homolog (Protein Gx or SMO).
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for Smoothened Homolog (Protein Gx or SMO). Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding Smoothened Homolog (Protein Gx or SMO) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
F. Hoffmann-La Roche Ltd
Genentech USA Inc
Guangdong Zhongsheng Pharmaceutical Co Ltd
IMPACT Therapeutics Inc
Kintor Pharmaceutical Ltd
Mayne Pharma Group Ltd
Nelum Corp
Nostopharma LLC
PellePharm Inc
Pfizer Inc
Sun Pharma Advanced Research Company Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What is the mechanism in action of the Smoothened Homolog pipeline drugs market?
The mechanism of action in the Smoothened Homolog pipeline drugs market is Smoothened Homolog Antagonist.
-
What are the routes of administration in the Smoothened Homolog pipeline drugs market?
The routes of administration in the Smoothened Homolog pipeline drugs market are oral and topical.
-
What is the molecule type in the Smoothened Homolog pipeline drugs market?
The molecule type in the Smoothened Homolog pipeline drugs market is small molecule.
-
Which are the key companies in the Smoothened Homolog pipeline drugs market?
The key companies in the Smoothened Homolog pipeline drugs market are Pfizer Inc, Alfasigma SpA, F. Hoffmann-La Roche Ltd, Genentech USA Inc, Guangdong Zhongsheng Pharmaceutical Co Ltd, IMPACT Therapeutics Inc, Kintor Pharmaceutical Ltd, Mayne Pharma Group Ltd, Nelum Corp, Nostopharma LLC, and PellePharm Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.